A Fuks

1.6k total citations
39 papers, 1.3k citations indexed

About

A Fuks is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, A Fuks has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in A Fuks's work include Monoclonal and Polyclonal Antibodies Research (16 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Glycosylation and Glycoproteins Research (6 papers). A Fuks is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (16 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Glycosylation and Glycoproteins Research (6 papers). A Fuks collaborates with scholars based in Canada, United States and Netherlands. A Fuks's co-authors include Clifford P. Stanners, Nicole Beauchemin, Hua Zhou, Denis Cournoyer, Sarita Benchimol, M. Rojas, Eleanor Colle, Ronald D. Guttmann, Charles Weijer and Gisèle Alcaraz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

A Fuks

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Fuks Canada 20 570 533 333 287 181 39 1.3k
A.A. Verstraeten Netherlands 20 371 0.7× 590 1.1× 402 1.2× 279 1.0× 75 0.4× 31 1.3k
Paul Chien United States 19 601 1.1× 565 1.1× 675 2.0× 85 0.3× 228 1.3× 40 1.5k
W.P. Zeijlemaker Netherlands 22 456 0.8× 380 0.7× 957 2.9× 171 0.6× 143 0.8× 47 1.7k
Ronald Billing United States 21 360 0.6× 542 1.0× 770 2.3× 200 0.7× 83 0.5× 74 1.6k
G. Michael Iverson United States 22 488 0.9× 449 0.8× 783 2.4× 69 0.2× 211 1.2× 45 2.0k
Cécile Tonnelle France 23 459 0.8× 559 1.0× 1.0k 3.1× 182 0.6× 70 0.4× 55 1.9k
R F Graziano United States 18 814 1.4× 616 1.2× 807 2.4× 300 1.0× 139 0.8× 26 1.5k
L M Pilarski Canada 24 295 0.5× 513 1.0× 816 2.5× 242 0.8× 158 0.9× 50 1.5k
Alton C. Morgan United States 14 546 1.0× 392 0.7× 313 0.9× 201 0.7× 49 0.3× 23 1.1k
Richard A. Patrick United States 8 214 0.4× 298 0.6× 877 2.6× 157 0.5× 114 0.6× 16 1.5k

Countries citing papers authored by A Fuks

Since Specialization
Citations

This map shows the geographic impact of A Fuks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Fuks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Fuks more than expected).

Fields of papers citing papers by A Fuks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Fuks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Fuks. The network helps show where A Fuks may publish in the future.

Co-authorship network of co-authors of A Fuks

This figure shows the co-authorship network connecting the top 25 collaborators of A Fuks. A scholar is included among the top collaborators of A Fuks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Fuks. A Fuks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shuster, J., David M. Thomson, A Fuks, & Phil Gold. (2015). Immunologic Approaches to Diagnosis of Malignancy. Progress in tumor research. 25. 89–139.
2.
Deutsch, D., Boaz Shay, A. Taylor, et al.. (2002). The Human Tuftelin Gene and the Expression of Tuftelin in Mineralizing and Nonmineralizing Tissues. Connective Tissue Research. 43(2-3). 425–434. 48 indexed citations
3.
Weijer, Charles, et al.. (1998). Assessing the interpretation of criteria for clinical trial eligibility: a survey of oncology investigators.. PubMed. 21(1). 17–26. 5 indexed citations
4.
Fuks, A, Eleanor Colle, & Guttmann Rd. (1995). Recombinant haplotype bearing the lymphopenia gene of the BB rat.. PubMed. 12(1). 48–52. 2 indexed citations
5.
Weijer, Charles, et al.. (1995). Monitoring clinical research: an obligation unfulfilled.. PubMed. 152(12). 1973–80. 41 indexed citations
6.
Jessup, J. Milburn, Peter Thomas, Shoken Ishii, et al.. (1993). Adhesion to carcinoembryonic antigen by human colorectal carcinoma cells involves at least two epitopes. International Journal of Cancer. 55(2). 262–268. 33 indexed citations
7.
Parfrey, Nollaig A., Gérald J. Prud’homme, Eleanor Colle, et al.. (1989). Immunologic and genetic studies of diabetes in the BB rat.. PubMed. 9(1). 45–65. 29 indexed citations
8.
Beauchemin, Nicole, Claire Turbide, Daniel Afar, et al.. (1989). A mouse analogue of the human carcinoembryonic antigen.. PubMed. 49(8). 2017–21. 43 indexed citations
9.
Cournoyer, Denis, et al.. (1988). Transcription of genes of the carcinoembryonic antigen family in malignant and nonmalignant human tissues.. PubMed. 48(11). 3153–7. 52 indexed citations
10.
Jothy, S, et al.. (1986). Characterization of monoclonal antibodies to carcinoembryonic antigen with increased tumor specificity.. PubMed. 54(1). 108–17. 41 indexed citations
11.
Fuks, A, et al.. (1985). Plasma membrane orientation of simian virus 40 T antigen in three transformed cell lines mapped with monoclonal antibodies. Journal of Virology. 53(2). 366–373. 11 indexed citations
12.
Nichols, E J, Reiji Kannagi, S Hakomori, Mark J. Krantz, & A Fuks. (1985). Carbohydrate determinants associated with carcinoembryonic antigen (CEA).. The Journal of Immunology. 135(3). 1911–1913. 33 indexed citations
13.
Prud’homme, Gérald J., A Fuks, Eleanor Colle, Thomas A. Seemayer, & Ronald D. Guttmann. (1984). Immune dysfunction in diabetes-prone BB rats. Interleukin 2 production and other mitogen-induced responses are suppressed by activated macrophages.. The Journal of Experimental Medicine. 159(2). 463–478. 67 indexed citations
14.
Tsoukas, Chris, Francine Gervais, A Fuks, et al.. (1984). Immunological Dysfunction and Persistent Lymphadenopathy in Patients with Classic Hemophilia. Scandinavian Journal of Haematology. 33(S40). 383–390. 2 indexed citations
15.
Guidoni, L., Carl O’Hara, Gerald B. Price, J. Shuster, & A Fuks. (1984). Targeting of liposomes: monoclonal antibodies coupled to phospholipid vesicles provide selective transfer of trapped reagents into cultured cells.. PubMed. 5(1). 61–73. 4 indexed citations
16.
Fuks, A, et al.. (1980). [Immunosuppression in systemic lupus erythematosus. Effect of cyclophosphamide and corticoids on lymphocyte subpopulations].. PubMed. 39(3). 289–97. 4 indexed citations
17.
Solheim, Bjarte G., A Fuks, Lloyd M. Smith, Jack L. Strominger, & Erik Thorsby. (1978). Possible Detection of HLA‐DR Alloantigenic Specificities in Man with Unabsorbed Rabbit Antisera. Scandinavian Journal of Immunology. 8(1). 15–20. 29 indexed citations
18.
Strominger, Jack L., William S. Ferguson, A Fuks, et al.. (1978). Isolation and structure of HLA antigens.. PubMed. 14(2). 235–46. 4 indexed citations
19.
Fuks, A, et al.. (1977). Structural aspects of the products of the human major histocompatibility complex.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 9(4). 1685–9. 3 indexed citations
20.
Fuks, A. (1975). Carcinoembryonic antigen (CEA): Molecular biology and clinical significance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 417(2). 123–152. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026